Abstract: The invention relates to a novel ester, the 3,5-di-tertiobutyl-4-hydroxybenzoate of 3,4,5-trihydroxy-6-methoxytetrahydropyran-2-yl methyl defined by the following formula (I). The invention also relates to the method for preparing the compound of formula (I) and to the use of said compound (I) to prepare a drug for treating and/or preventing enveloped virus infections.

Abstract: The invention relates to a D-glucopyranose 1-[3,5-bis(1,1-dimethyl-ethyl)-4-hydroxybenzoate compound defined by formula (I). It applies in particular to the preparation and the use of this compound and of its derivatives for the preparation of medicaments for the treatment and/or prevention of infections with enveloped viruses, and in particular, in humans, the herpes virus, the Aids virus, the flu virus, the hepatitis B virus, the hepatitis C virus, the dengue virus and the ebola virus, and, in animals, the porcine pseudorabies virus, for example.

Abstract: The invention concerns a method which consists in preventing oxidation of an active oxygen-sensitive compound of a medicinal and/or cosmetic formulation including at least a strong antioxidant and at least a weak antioxidant with high coating capacity, the strong antioxidant reacting with the oxygen before the active compound and the weak antioxidant reacting with the residual oxygen to form, after oxidation, highly coating particles which aggregate by micronization around the active compound to form a protective plaster. The invention is applicable in particular to compounds derived from 2,6-di-tert-butylphenol.

Abstract: The present invention concerns a novel therapeutic compositions comprising a phenol component and propolis which is useful in combating lipidic capside viruses, which contains (1) 100 to 650 parts by weight of phenol component for (ii) one part by weight of propolis. This novel composition is especially useful in the treatment of herpes, especially the diseases caused by the virus strains HSV.sub.1, HSV.sub.2 HSV.sub.1 R.

Abstract: A therapeutical use is provided for cornpounds selected from the group which consists of (a) phenols of formula (I): ##STR1## wherein R is a C1-12 alkyl group, a C2-12 alkenyl group, a C2-12 alkynyl group, a C1-12 alkoxy group, a formyl group, a C2-12 alkanoyl group, a C1-12 hydroxyalkyl group, a primary, secondary or tertiary amide group, an OCH.sub.3 group, CH.sub.2 OH or a COOH group or an A--COOH group where A is a C1-11 aliphatic hydrocarbon residue; and (b) the corresponding salts and esters thereof when R is COOH or A--COOH; for obtaining an antiviral drug for use in the human or veterinary therapeutical treatment of viral diseases.